What is the typical Selank dose?
Preclinical Selank research protocols typically use 100-500 mcg per dose with intranasal administration as the dominant route across the Russian-research-group literature. Subcutaneous administration is less common but has been characterised in some protocols.
What the research literature says
The Selank dose framework is informed by the Russian-research-group literature that dominates the compound’s published research base. The Volkova GABAergic-neurotransmission work (PMID 26924987), the Filatova IMR-32 cell follow-up (PMID 28293190), and the Kolik ethanol-induced memory impairment work (PMID 31625062) used dose tiers in the 100-500 mcg per-dose range with administration routes adapted to the experimental context.
Stress-response and cytokine-modulation work (PMID 32621722 social stress; PMID 31243679 chronic foot-shock) used similar dose tiers. The Konstantinopolsky morphine-withdrawal work documented dose-response considerations across an additional research context (PMID 36322304).
The compound is approved for clinical use in the Russian Federation; the clinical dose-framework provides additional anchoring data but the Western-regulator approval context is absent. Research-supply protocols anchor to the published preclinical and Russian-clinical-research framework.
Why this matters in research context
Selank’s dose framework reflects the concentration of the published research in a single research lineage and the Russian-Federation clinical-use context. Researchers selecting Selank should anchor protocol design to the specific cited literature and apply appropriate caveats about cross-laboratory replication outside the Russian research community.
Related compounds
- Selank 10mg — the compound covered by this answer
Related research questions
References
- Volkova A et al. Selank Administration Affects the Expression of Some Genes Involved in GABAergic Neurotransmission. Front Pharmacol 2016;7:31. [PMID 26924987]
- Kolik LG et al. Selank, Peptide Analogue of Tuftsin, Protects Against Ethanol-Induced Memory Impairment by Regulating of BDNF Content in the Hippocampus and Prefrontal Cortex in Rats. Bull Exp Biol Med 2019;167(5):641-644. [PMID 31625062]
- Konstantinopolsky MA et al. Selank, a Peptide Analog of Tuftsin, Attenuates Aversive Signs of Morphine Withdrawal in Rats. Bull Exp Biol Med 2022;173(6):741-744. [PMID 36322304]
Research-questions pages describe research-context use of peptide-research terminology. They do not constitute medical, veterinary, or clinical advice. Selank is sold strictly as a research-grade reagent for laboratory and bench research applications.